These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first? Fang JC Circulation; 2005 Oct; 112(16):2380-2. PubMed ID: 16230494 [No Abstract] [Full Text] [Related]
23. Beta-blockade for patients with heart failure. Wiener DH JAMA; 2000 Jul; 284(4):436; author reply 436-7. PubMed ID: 10904493 [No Abstract] [Full Text] [Related]
24. [Therapy of heart failure. Which patients does the AT1 blocker help?]. Böhm M MMW Fortschr Med; 2003 Sep; 145(38):8. PubMed ID: 14603671 [No Abstract] [Full Text] [Related]
25. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia? Smith I; Jackson I Curr Opin Anaesthesiol; 2010 Dec; 23(6):687-90. PubMed ID: 20805745 [TBL] [Abstract][Full Text] [Related]
27. Therapy with ACE inhibitors and ARBs in heart failure. Cayley WE Am Fam Physician; 2004 Jul; 70(2):261. PubMed ID: 15291087 [No Abstract] [Full Text] [Related]
28. [New prospects in diagnosis and treatment of heart failure]. Pfister U; Lerch R; Hess OM Praxis (Bern 1994); 2002 Jan; 91(5):177-80. PubMed ID: 11865776 [No Abstract] [Full Text] [Related]
29. [Use of beta-blockaders in heart failure]. Gullestad L; Kjekshus J Tidsskr Nor Laegeforen; 2003 Mar; 123(5):651-2. PubMed ID: 12683197 [No Abstract] [Full Text] [Related]
30. Role of neurohormonal modulators in heart failure with relatively preserved systolic function. Rapp JA; Gheorghiade M Cardiol Clin; 2008 Feb; 26(1):23-40, vi. PubMed ID: 18312903 [TBL] [Abstract][Full Text] [Related]
31. Does the target dose of neurohormonal blockade matter for outcome in Systolic heart failure in octogenarians? Barywani SB; Ergatoudes C; Schaufelberger M; Petzold M; Fu ML Int J Cardiol; 2015; 187():666-72. PubMed ID: 25880407 [TBL] [Abstract][Full Text] [Related]
32. Heart failure--role of ACE inhibitors and beta-blocker in its treatment. Patel JC Indian J Med Sci; 1999 Oct; 53(10):447-50. PubMed ID: 10776502 [No Abstract] [Full Text] [Related]
35. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function. Shah R; Wang Y; Foody JM Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410 [TBL] [Abstract][Full Text] [Related]
36. Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis. Raimondi S; Botteri E; Munzone E; Cipolla C; Rotmensz N; DeCensi A; Gandini S Int J Cancer; 2016 Jul; 139(1):212-9. PubMed ID: 26916107 [TBL] [Abstract][Full Text] [Related]
37. ACP Journal Club: in HF, angiotensin-neprilysin inhibition reduced mortality and HF hospitalization compared with enalapril. Schmitt BP Ann Intern Med; 2015 Feb; 162(4):JC2. PubMed ID: 25686189 [No Abstract] [Full Text] [Related]
38. [Should beta-adrenergic blockade be part of drug therapy for heart failure?]. Leinonen H Duodecim; 1995; 111(3):209-13. PubMed ID: 8654281 [No Abstract] [Full Text] [Related]
39. Treatment with beta-blockers in nurse-led heart failure clinics: titration efficacy and predictors of failure. Gustafsson F; Schou M; Videbaek L; Nielsen T; Ulriksen H; Markenvard J; Svendsen TL; Ryde H; Vigholt E; Hildebrandt P; Eur J Heart Fail; 2007 Sep; 9(9):910-6. PubMed ID: 17572146 [TBL] [Abstract][Full Text] [Related]